Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012: Globocan 2012, Int. J. Cancer, vol.136, pp.359-386, 2015. ,
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States, Cancer Res, vol.74, pp.2913-2921, 2014. ,
Genome-wide aberrations in pancreatic adenocarcinoma, Cancer Genet. Cytogenet, vol.161, pp.36-50, 2005. ,
A randomized controlled trial of adjuvant immunotherapy (murine monoclonal antibody 494/32) in resectable pancreatic cancer, Cancer, vol.68, pp.1507-1512, 1991. ,
Treatment of duct carcinoma of the pancreas with the LH-RH analogue buserelin, Pancreas, vol.7, pp.516-521, 1992. ,
Localized Pancreatic Cancer: Multidisciplinary Management ,
Prognosis of resected pancreatic cancer: is the refined resection margin status dispensable?, Langenbecks Arch. Surg, vol.397, pp.859-860, 2012. ,
Accomplishments in 2007 in the Treatment of Metastatic Pancreatic Cancer, Gastrointest. Cancer Res. GCR, vol.2, pp.37-41, 2008. ,
Pancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 Trial, JNCI J. Natl. Cancer Inst, vol.106, 2014. ,
The Role of Radiation Therapy for Pancreatic Cancer in the Adjuvant and Neoadjuvant Settings, Surg. Oncol. Clin. N. Am, vol.26, pp.431-453, 2017. ,
Improvements in survival and clinical benefit with gemcitabine as firstline therapy for patients with advanced pancreas cancer: a randomized trial, J. Clin. Oncol, vol.15, pp.2403-2413, 1997. ,
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer ,
, Engl. J. Med, vol.9, 2011.
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus ! 24 ,
, N. Engl. J. Med, vol.369, pp.1691-1703, 2013.
Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial, JAMA, vol.315, p.1844, 2016. ,
Cancer statistics, CA. Cancer J. Clin, vol.64, pp.9-29, 2014. ,
, N. Engl. J. Med, vol.362, pp.1605-1617, 2010.
The role of stroma in pancreatic cancer: diagnostic and therapeutic implications, Nat. Rev. Gastroenterol. Hepatol, vol.9, pp.454-467, 2012. ,
Hallmarks of Cancer: The Next Generation, Cell, vol.144, pp.646-674, 2011. ,
The Activated Stroma Index Is a Novel and Independent Prognostic Marker in Pancreatic Ductal Adenocarcinoma, Clin. Gastroenterol. Hepatol, vol.6, pp.1155-1161, 2008. ,
Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer, Cancer Cell, vol.33, pp.463-479, 2018. ,
Inter-and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma: CAF heterogeneity in pancreatic cancer, J. Pathol, 2019. ,
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer, J. Exp. Med. jem, p.20162024, 2017. ,
The immunobiology of cancer immunosurveillance and immunoediting, Immunity, vol.21, pp.137-148, 2004. ,
Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome, Science, vol.313, pp.1960-1964, 2006. ,
Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma, Cancer, vol.77, pp.1303-1310, 1996. ,
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group, Ann. Oncol. Off. J. Eur. Soc, 2014. ,
, Med. Oncol, vol.26, pp.259-271, 2015.
Prognostic Role of Tumor-Infiltrating Lymphocytes in Lung Cancer: a Meta-! 25 ,
, Analysis. Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol, vol.37, pp.1560-1571, 2015.
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer ,
, J. Med, vol.348, pp.203-213, 2003.
Effector memory T cells, early metastasis, and survival in colorectal cancer ,
, J. Med, vol.353, pp.2654-2666, 2005.
Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses Tcell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner ,
, Clin. Immunol. Orlando Fla, vol.134, pp.277-288, 2010.
Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer, Cancer Res, vol.67, pp.8344-8350, 2007. ,
FOXP3+ Lymphocyte Density in Pancreatic Cancer Correlates with Lymph Node Metastasis, PLoS ONE, vol.9, p.106741, 2014. ,
Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.24, pp.5373-5380, 2006. ,
Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients, Gastroenterology, vol.132, pp.2328-2339, 2007. ,
Infiltrating memory/senescent T cell ratio predicts extrahepatic metastasis of hepatocellular carcinoma, Ann. Surg. Oncol, vol.19, pp.455-466, 2012. ,
The ratio of intra-tumoral regulatory T cells (Foxp3+)/helper T cells (CD4+) is a prognostic factor and associated with recurrence pattern in gastric cardia cancer, J. Surg. Oncol, vol.104, pp.728-733, 2011. ,
Tumor infiltrating Foxp3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients, Cancer, vol.107, pp.2866-2872, 2006. ,
Intraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma, Gastroenterology, vol.137, pp.1270-1279, 2009. ,
The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis ,
, Br. J. Cancer, vol.105, pp.93-103, 2011.
Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large ,
, Ann. Surg. Oncol, vol.15, pp.165-174, 2008.
Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.24, pp.2897-2902, 2006. ,
,
, American Joint Commission on Cancer (AJCC) 8th Edition Staging System for Patients with Pancreatic Adenocarcinoma: A Surveillance, Epidemiology and End Results (SEER) Analysis
, Ann. Surg. Oncol, vol.24, pp.2023-2030, 2017.
Immune Cell and Stromal Signature Associated With Progression-Free Survival of Patients With Resected Pancreatic Ductal Adenocarcinoma, Gastroenterology, vol.155, pp.1625-1639, 2018. ,
The desmoplastic stroma plays an essential role in the accumulation and modulation of infiltrated immune cells in pancreatic adenocarcinoma, Clin. Dev. Immunol, p.212810, 2011. ,
Accumulation of FOXP3+T-cells in the tumor microenvironment is associated with an epithelial-mesenchymal-transition-type tumor budding phenotype and is an independent prognostic factor in surgically resected pancreatic ductal adenocarcinoma, Oncotarget, vol.6, 2015. ,
Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer, Br. J. Cancer, vol.108, pp.914-923, 2013. ,
Prognostic Impact of Tumor-Infiltrating Lymphocytes and Neutrophils on Survival of Patients with Upfront Resection of Pancreatic Cancer, Cancers, vol.11, 2019. ,
Defining the molecular pathology of pancreatic body and tail adenocarcinoma: Molecular pathology of pancreatic body and tail adenocarcinoma, Br. J. Surg, vol.105, pp.183-191, 2018. ,
Prognostic impact of the tumor-infiltrating regulatory T-cell (Foxp3+)/ activated cytotoxic T lymphocyte (granzyme B+) ratio on resected left-sided pancreatic cancer ,
, Oncol. Lett, vol.12, pp.4477-4484, 2016.
Distinct and Complementary Information Provided by Use of Tissue and DNA Microarrays in the Study of Breast Tumor Markers, Am. J. Pathol, vol.161, pp.1223-1233, 2002. ,
Classification OMS 2010 des tumeurs digestives : la quatrième édition, Ann. Pathol, vol.31, pp.27-31, 2011. ,
Pancreatic cancer, Nat. Rev. Dis. Primer, vol.2, p.16022, 2016. ,
Whole genomes redefine the mutational landscape of pancreatic cancer, Nature, vol.518, pp.495-501, 2015. ,
Subtypes of Pancreatic Ductal Adenocarcinoma and Their Differing Responses to Therapy, Nat. Med, vol.17, pp.500-503, 2011. ,
Genomic analyses identify molecular subtypes of pancreatic cancer, Nature, vol.531, pp.47-52, 2016. ,
Virtual microdissection identifies distinct tumor-and stroma-specific subtypes of pancreatic ductal adenocarcinoma, Nat. Genet, vol.47, pp.1168-1178, 2015. ,
Prognostic Nomogram for Patients Undergoing Resection for Adenocarcinoma of the Pancreas, Ann. Surg, vol.240, pp.293-298, 2004. ,
, Annu. Rev. Pathol, vol.3, pp.157-188, 2008.
Pancreatic cancer stroma: Understanding biology leads to new therapeutic strategies, World J. Gastroenterol, vol.20, pp.2237-2246, 2014. ,
Stromal biology of pancreatic cancer, J. Cell. Biochem, vol.101, pp.887-907, 2007. ,
The Pancreas Cancer Microenvironment, Clin. Cancer Res, vol.18, pp.4266-4276, 2012. ,
Deciphering the role of stroma in pancreatic cancer, Curr. Opin. Gastroenterol, vol.29, pp.537-543, 2013. ,
Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.28, pp.105-113, 2010. ,
Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patients, Ann. Oncol. Off. J. Eur. Soc. Med. Oncol, vol.25, pp.1536-1543, 2014. ,
Durable Tumor Remission, and Long-Term Safety in Patients ! 28, Survival ,
, With Advanced Melanoma Receiving Nivolumab, J. Clin. Oncol, vol.32, pp.1020-1030, 2014.
, A Lung Cancer Journey, vol.35, pp.243-252, 1973.
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer ,
, J. Med, vol.367, pp.1783-1791, 2012.
Mismatch repair deficient colorectal cancer in the era of personalized treatment, Nat. Rev. Clin. Oncol, vol.7, pp.197-208, 2010. ,
Overcoming the resistance of pancreatic cancer to immune checkpoint inhibitors, J. Surg. Oncol, vol.116, pp.55-62, 2017. ,
Resection margins and R1 rates in pancreatic cancer -are we there yet?, Histopathology, vol.52, pp.787-796, 2008. ,
Redefining resection margin status in pancreatic cancer, HPB, vol.11, pp.282-289, 2009. ,
, Chemical Immunology and Allergy, vol.100, pp.155-164, 2014.
The presence of tumour-associated lymphocytes confers a good prognosis in pancreatic ductal adenocarcinoma: an immunohistochemical study of tissue microarrays, BMC Cancer, vol.13, p.436, 2013. ,
Prognostic and predictive value of immunological parameters for chemoradioimmunotherapy in patients with pancreatic adenocarcinoma, Br. J. Cancer, vol.112, pp.1027-1036, 2015. ,
High immune cell score predicts improved survival in pancreatic cancer, Virchows Arch. Int. J. Pathol, vol.472, pp.653-665, 2018. ,
Prognostic Significance of Tumor Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Chemotherapy, Pancreas, vol.46, pp.1180-1187, 2017. ,
Control of T-Cell-Mediated Immune Response by HLA Class I in Human Pancreatic Carcinoma ,
Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces ! 29 ,
, Immunosuppression and Accelerates Pancreas Cancer with Diminished Survival, Cancer Cell, vol.25, pp.719-734, 2014.
Cancer-associated fibroblasts enhance pancreatic cancer cell invasion by remodeling the metabolic conversion mechanism, Oncol. Rep, vol.37, pp.1971-1979, 2017. ,
Vimentin on the move: new developments in cell migration, F1000Research, vol.7, 2018. ,
The biology and function of fibroblasts in cancer, Nat. Rev. Cancer, vol.16, pp.582-598, 2016. ,
Immune Checkpoint Blockade in Cancer Therapy, J. Clin. Oncol, vol.33, pp.1974-1982, 2015. ,
Prognostic value of PDL1 expression in pancreatic cancer, Oncotarget, vol.7, pp.71198-71210, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01765421
Ki67 assessment in breast cancer: an update, Pathology (Phila.), vol.49, p.30, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01675161